AAAAAA

   
Results: 1-25 | 26-27
Results: 1-25/27

Authors: LAN K SARVAZYAN NA TAUSSIG R MACKENZIE RG DOHLMAN HG NEUBIG RR
Citation: K. Lan et al., A POINT MUTATION OF G(ALPHA-0) AND G(ALPHA-1) BLOCKS INTERACTIONS WITH RGS PROTEINS, The FASEB journal, 12(4), 1998, pp. 721-721

Authors: WHELAN TJ LADA BM LAUKKANEN E PERERA FE SHELLEY WE LEVINE MN OLIVOTTO IA THAIN SK FIRTH LA BOUCHARD F MCGREGOR M FREEMAN C ROUSSEAU P ACKERMAN I BELLEFONTAINE P BOTTORFF J DOHERTY MA FYLES AN LAVERDIERE J MACKENZIE RG MANCHAL LA MCGREGOR GI MERCIER JP METHOT F NIELSEN E SAMANT R STARREVELD A WONG O
Citation: Tj. Whelan et al., BREAST RADIOTHERAPY AFTER BREAST-CONSERVING SURGERY, CMAJ. Canadian Medical Association journal, 158, 1998, pp. 35-42

Authors: LAN KL SARVAZYAN NA TAUSSIG R MACKENZIE RG DIBELLO PR DOHLMAN HG NEUBIG RR
Citation: Kl. Lan et al., A POINT MUTATION IN G-ALPHA(O) AND G-ALPHA(I1) BLOCKS INTERACTION WITH REGULATOR OF G-PROTEIN SIGNALING PROTEINS, The Journal of biological chemistry, 273(21), 1998, pp. 12794-12797

Authors: PEPPERL DJ SHAHBASU S VANLEEUWEN D GRANNEMAN JG MACKENZIE RG
Citation: Dj. Pepperl et al., REGULATION OF RGS MESSENGER-RNAS BY CAMP IN PC12 CELLS, Biochemical and biophysical research communications, 243(1), 1998, pp. 52-55

Authors: WRIGHT JL GREGORY TF HEFFNER TG MACKENZIE RG PUGSLEY TA MEULEN SV WISE LD
Citation: Jl. Wright et al., DISCOVERY OF SELECTIVE DOPAMINE D4 RECEPTOR ANTAGONISTS - 1-ARYLOXY-3-(4-ARYLOXYPIPERIDINYL)-2-PROPANOLS, Bioorganic & medicinal chemistry letters, 7(11), 1997, pp. 1377-1380

Authors: PALDA VA LLEWELLYNTHOMAS HA MACKENZIE RG PRITCHARD KI NAYLOR CD
Citation: Va. Palda et al., BREAST-CANCER PATIENTS ATTITUDES ABOUT RATIONING POSTLUMPECTOMY RADIATION-THERAPY - APPLICABILITY OF TRADE-OFF METHODS TO POLICY-MAKING, Journal of clinical oncology, 15(10), 1997, pp. 3192-3200

Authors: UNANGST PC CAPIRIS T CONNOR DT DOUBLEDAY R HEFFNER TG MACKENZIE RG MILLER SR PUGSLEY TA WISE LD
Citation: Pc. Unangst et al., (ARYLOXY)ALKYLAMINES AS SELECTIVE HUMAN DOPAMINE D-4 RECEPTOR ANTAGONISTS - POTENTIAL ANTIPSYCHOTIC AGENTS, Journal of medicinal chemistry, 40(25), 1997, pp. 4026-4029

Authors: UNANGST PC CAPIRIS T CONNOR DT HEFFNER TG MACKENZIE RG MILLER SR PUGSLEY TA WISE LD
Citation: Pc. Unangst et al., CHROMENO[3,4-C]PYRIDIN-5-ONES - SELECTIVE HUMAN DOPAMINE D-4 RECEPTORANTAGONISTS AS POTENTIAL ANTIPSYCHOTIC AGENTS, Journal of medicinal chemistry, 40(17), 1997, pp. 2688-2693

Authors: GLASE SA AKUNNE HC GEORGIC LM HEFFNER TG MACKENZIE RG MANLEY PJ PUGSLEY TA WISE LD
Citation: Sa. Glase et al., SUBSTITUTED [(4-PHENYLPIPERAZINYL)METHYL]BENZAMIDES - SELECTIVE DOPAMINE D-4 AGONISTS, Journal of medicinal chemistry, 40(12), 1997, pp. 1771-1772

Authors: GLAUM SR MILLER RJ RHIM H MACLEAN D GEORGIC LM MACKENZIE RG GRUNDEMAR L
Citation: Sr. Glaum et al., CHARACTERIZATION OF Y-3 RECEPTOR-MEDIATED SYNAPTIC INHIBITION BY CHIMERIC NEUROPEPTIDE Y-PEPTIDE YY PEPTIDES IN THE RAT BRAIN-STEM, British Journal of Pharmacology, 120(3), 1997, pp. 481-487

Authors: GLASE SA AKUNNE HC HEFFNER TG JOHNSON SJ KESTEN SR MACKENZIE RG MANLEY PJ PUGSLEY TA WRIGHT JL WISE LD
Citation: Sa. Glase et al., RYL-1-PIPERAZINYL)ETHYL]-2-NAPHTHALENECARBOXAMIDES - SELECTIVE DOPAMINE D-3 RECEPTOR PARTIAL AGONISTS, Bioorganic & medicinal chemistry letters, 6(12), 1996, pp. 1361-1366

Authors: GLASE SA AKUNNE HC HEFFNER TG JAEN JC MACKENZIE RG MELTZER LT PUGSLEY TA SMITH SJ WISE LD
Citation: Sa. Glase et al., ARYL 1-BUT-3-YNYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINES AS POTENTIAL ANTIPSYCHOTIC AGENTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS, Journal of medicinal chemistry, 39(16), 1996, pp. 3179-3187

Authors: KIPKE MD OCONNOR S PALMER R MACKENZIE RG
Citation: Md. Kipke et al., STREET YOUTH IN LOS-ANGELES - PROFILE OF A GROUP AT HIGH-RISK FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Archives of pediatrics & adolescent medicine, 149(5), 1995, pp. 513-519

Authors: WANG S DREXINGER M RADZIK M MACKENZIE RG
Citation: S. Wang et al., PSYCHOSOCIAL ISSUES OF HIV-POSITIVE TRANSGENDER MALE YOUTH, Journal of adolescent health, 16(2), 1995, pp. 166-166

Authors: VANLEEUWEN DH EISENSTEIN J OMALLEY K MACKENZIE RG
Citation: Dh. Vanleeuwen et al., CHARACTERIZATION OF A CHIMERIC HUMAN DOPAMINE D3 D2 RECEPTOR FUNCTIONALLY COUPLED TO ADENYLYL-CYCLASE IN CHINESE-HAMSTER OVARY CELLS/, Molecular pharmacology, 48(2), 1995, pp. 344-351

Authors: PUGSLEY TA DAVIS MD AKUNNE HC MACKENZIE RG SHIH YH DAMSMA G WIKSTROM H WHETZEL SZ GEORGIC LM COOKE LW DEMATTOS SB CORBIN AE GLASE SA WISE LD DIJKSTRA D HEFFNER TG
Citation: Ta. Pugsley et al., NEUROCHEMICAL AND FUNCTIONAL-CHARACTERIZATION OF THE PREFERENTIALLY SELECTIVE DOPAMINE D3 AGONIST PD-128907, The Journal of pharmacology and experimental therapeutics, 275(3), 1995, pp. 1355-1366

Authors: PUGSLEY TA DAVIS MD AKUNNE HC COOKE LW WHETZEL SZ MACKENZIE RG SHIH YH VANLEEUWEN DH DEMATTOS SB GEORGIC LM CAPRATHE BW WRIGHT JC JAEN JC WISE LD HEFFNER TG
Citation: Ta. Pugsley et al., CI-1007, A DOPAMINE PARTIAL AGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT.1. NEUROCHEMICAL EFFECTS, The Journal of pharmacology and experimental therapeutics, 274(2), 1995, pp. 898-911

Authors: WRIGHT JL DOWNING DM FENG MR HAYES RN HEFFNER TG MACKENZIE RG MELTZER LT PUGSLEY TA WISE LD
Citation: Jl. Wright et al., IDENTIFICATION, CHARACTERIZATION AND PHARMACOLOGICAL PROFILE OF 3 METABOLITES OF PHENYL-1-[(3-PHENYLCYCLOHEXEN-1-YL)METHYL]PYRIDINE (CI-1007), A DOPAMINE AUTORECEPTOR AGONIST AND POTENTIAL ANTIPSYCHOTIC AGENT()), Journal of medicinal chemistry, 38(26), 1995, pp. 5007-5014

Authors: MACKENZIE RG VANLEEUWEN D PUGSLEY TA SHIH YH DEMATTOS S TANG L TODD RD OMALLEY KL
Citation: Rg. Mackenzie et al., CHARACTERIZATION OF THE HUMAN DOPAMINE D-3 RECEPTOR EXPRESSED IN TRANSFECTED CELL-LINES, European journal of pharmacology. Molecular pharmacology section, 266(1), 1994, pp. 79-85

Authors: CHAUDHRY A MACKENZIE RG GEORGIC LM GRANNEMAN JG
Citation: A. Chaudhry et al., DIFFERENTIAL INTERACTION OF BETA(1)-ADRENERGIC AND BETA(3)-ADRENERGICRECEPTORS WITH G(I) IN RAT ADIPOCYTES, Cellular signalling, 6(4), 1994, pp. 457-465

Authors: WUSTROW DJ WISE LD CODY DM MACKENZIE RG GEORGIC LM PUGSLEY TA HEFFNER TG
Citation: Dj. Wustrow et al., STUDIES OF THE ACTIVE CONFORMATION OF A NOVEL SERIES OF BENZAMIDE DOPAMINE D2 AGONISTS, Journal of medicinal chemistry, 37(24), 1994, pp. 4251-4257

Authors: WRIGHT JL CAPRATHE BW DOWNING DM GLASE SA HEFFNER TG JAEN JC JOHNSON SJ KESTEN SR MACKENZIE RG MELTZER LT PUGSLEY TA SMITH SJ WISE LD WUSTROW DJ
Citation: Jl. Wright et al., THE DISCOVERY AND STRUCTURE-ACTIVITY-RELATIONSHIPS OF YDRO-4-PHENYL-1-[(ARYLCYCLOHEXENYL)ALKYL]PYRIDINES - DOPAMINE AUTORECEPTOR AGONISTS AND POTENTIAL ANTIPSYCHOTIC AGENTS, Journal of medicinal chemistry, 37(21), 1994, pp. 3523-3533

Authors: KIPKE MD MONTGOMERY S MACKENZIE RG
Citation: Md. Kipke et al., SUBSTANCE USE AMONG YOUTH SEEN AT A COMMUNITY-BASED HEALTH CLINIC, Journal of adolescent health, 14(4), 1993, pp. 289-294

Authors: FRAIL DE MANELLI AM WITTE DG LIN CW STEFFEY ME MACKENZIE RG
Citation: De. Frail et al., CLONING AND CHARACTERIZATION OF A TRUNCATED DOPAMINE D1 RECEPTOR FROMGOLDFISH RETINA - STIMULATION OF CYCLIC-AMP PRODUCTION AND CALCIUM MOBILIZATION, Molecular pharmacology, 44(6), 1993, pp. 1113-1118

Authors: MACKENZIE RG STEFFEY ME MANELLI AM POLLOCK NJ FRAIL DE
Citation: Rg. Mackenzie et al., A D1 D2 CHIMERIC DOPAMINE RECEPTOR MEDIATES A D1 RESPONSE TO A D2-SELECTIVE AGONIST/, FEBS letters, 323(1-2), 1993, pp. 59-62
Risultati: 1-25 | 26-27